Canadians Find Better Way to Screen for Drug-resistant Prostate Cancer

Canadians Find Better Way to Screen for Drug-resistant Prostate Cancer
A new approach to detecting tumor cells in the blood offers a minimally invasive alternative to identifying prostate cancer patients who may not respond to first-line treatments, Canadian researchers report. They said the technology could be used to screen for drug-resistant tumor cells. The study describing their approach, “Single-cell mRNA cytometry via sequence-specific nanoparticle clustering

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *